News & Opinion

Covering the life sciences inside and out

Most Recent

Anthrax investigation plagues scientist

By | September 10, 2002

Steven Hatfill loses his job and his patience with FBI attention.

0 Comments

Making it to market

By | September 10, 2002

Have federal funds been a boon to the science of fighting terror?

0 Comments

Natural HIV inhibitors

By | September 10, 2002

Saturable intracellular inhibitors prevent HIV/SIV infection by targeting the lentiviral capsid.

0 Comments

One year after

By | September 10, 2002

How has terrorism altered the landscape of life science since 9-11?

0 Comments

Pheromone phenotypes

By | September 10, 2002

Disruption of a genomic cluster of pheromone receptors results in behavioral and chemosensory dysfunction.

0 Comments

Shifting sands

By | September 10, 2002

Scientists struggle to keep up with new regulations while protecting scientific freedom.

0 Comments

The aptness of aptamers

By | September 10, 2002

RNA aptamers can be used to create antidote-controlled anticoagulant agents.

0 Comments

UK e-Science grid goes live

By | September 10, 2002

The vision of almost unlimited computing power for biomedical research has taken a step forward.

0 Comments

Motif controls nicotinic receptors

By | September 9, 2002

A transmembrane motif controls the endoplasmic reticulum release of nicotinic acetylcholine receptor subunits.

0 Comments

Mutant candidate for TB vaccine

By | September 9, 2002

pantothenate auxotroph is highly attenuated and protects mice from tuberculosis.

0 Comments

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. Judge Recommends Ruling to Block Internet Access to Sci-Hub
  3. Opinion: Microbiology Needs More Math
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech